These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 17471773)
1. [Premature cardiovascular disease: no indication for the determination of antiphospholipid antibodies or lupus anticoagulant as a possible risk factor]. Wierema TK; Stehouwer CD Ned Tijdschr Geneeskd; 2007 Mar; 151(13):735-8. PubMed ID: 17471773 [TBL] [Abstract][Full Text] [Related]
2. [Primary antiphospholipid syndrome]. Popa A; Voinea L; Pop M; Stana D; Dascalu AM; Alexandrescu C; Ciuluvica R Oftalmologia; 2008; 52(1):13-7. PubMed ID: 18714484 [TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies: predictive value of laboratory tests. Galli M; Finazzi G; Barbui T Thromb Haemost; 1997 Jul; 78(1):75-8. PubMed ID: 9198131 [TBL] [Abstract][Full Text] [Related]
4. Neurological manifestations of the antiphospholipid syndrome: risk assessments and evidence-based medicine. Muscal E; Brey RL Int J Clin Pract; 2007 Sep; 61(9):1561-8. PubMed ID: 17596187 [TBL] [Abstract][Full Text] [Related]
6. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies. Sanmarco M; Gayet S; Alessi MC; Audrain M; de Maistre E; Gris JC; de Groot PG; Hachulla E; Harlé JR; Sié P; Boffa MC Thromb Haemost; 2007 Jun; 97(6):949-54. PubMed ID: 17549297 [TBL] [Abstract][Full Text] [Related]
7. Venous thrombosis in the antiphospholipid syndrome. Farmer-Boatwright MK; Roubey RA Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism. de Laat B; Mertens K; de Groot PG Nat Clin Pract Rheumatol; 2008 Apr; 4(4):192-9. PubMed ID: 18285765 [TBL] [Abstract][Full Text] [Related]
10. How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive. Giles I; Rahman A Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):525-37. PubMed ID: 19591782 [TBL] [Abstract][Full Text] [Related]
11. [Warfarin in the treatment of antiphospholipid syndrome]. Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075 [TBL] [Abstract][Full Text] [Related]
12. Cardiac manifestations in antiphospholipid syndrome. Soltész P; Szekanecz Z; Kiss E; Shoenfeld Y Autoimmun Rev; 2007 Jun; 6(6):379-86. PubMed ID: 17537384 [TBL] [Abstract][Full Text] [Related]
13. Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women? Alijotas-Reig J; Casellas-Caro M; Ferrer-Oliveras R; Llurba-Olive E; Hermosilla E; Vilardell-Tarres M; Cabero-Roura L Am J Reprod Immunol; 2008 Sep; 60(3):229-37. PubMed ID: 18782284 [TBL] [Abstract][Full Text] [Related]
14. Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome. Devreese K; Hoylaerts MF Eur J Haematol; 2009 Jul; 83(1):1-16. PubMed ID: 19226362 [TBL] [Abstract][Full Text] [Related]
15. How much warfarin is enough in APS related thrombosis? Erkan D; Lockshin MD Thromb Res; 2004; 114(5-6):435-42. PubMed ID: 15507275 [TBL] [Abstract][Full Text] [Related]
16. Management of the neurological manifestations of APS--what do the trials tell us? Brey RL Thromb Res; 2004; 114(5-6):489-99. PubMed ID: 15507283 [TBL] [Abstract][Full Text] [Related]
17. Lupus anticoagulants and anti-phospholipid antibodies as risk factors for a first episode of ischemic stroke. Saidi S; Mahjoub T; Almawi WY J Thromb Haemost; 2009 Jul; 7(7):1075-80. PubMed ID: 19422448 [TBL] [Abstract][Full Text] [Related]